University Hospital
Tours, 37044, France
NCT Number: NCT03002142
Alzheimer disease is a neurodegenerative disease. Recent studies suggest that subjects with hearing loss are more likely to develop Alzheimer's disease. Hearing loss can be consecutive to presbycusis and/or to central auditory dysfunction.
Standard audiometric measures with pure tone and speech intelligibility allow the diagnosis of presbycusis. However, to demonstrate central auditory dysfunction, specific audiometric tests as noisy and/or dichotic tests, are needed.
Actually, no consensus exists to investigate hearing loss in people with Alzheimer's disease; therefore hearing loss may be an early manifestation of Alzheimer's disease. Until now, investigations and clinical procedure related to the diagnosis of Alzheimer's disease ignored the hearing ability of the patient. However, the major part of care management and investigations implies the patient's communication ability with caregivers. Hearing loss may be one of the most unrecognized deficit in subjects with Alzheimer's disease. Auditory rehabilitation with hearing aids could benefit to the patient to decrease cognitive decline but this management must be investigate during longitudinal studies in order to demonstrate their efficiency and need to be compared with a placebo.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Tours, 37044, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Phonak Audéo B-R (Target V 5.0)
Phonak Audéo B-R (Target V 5.0) without amplification
Other names: Non functional hearing aids
Time frame: Change before and one year after the fitting with device
French scale validated by the french society of geriatry
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
Tonal audiometry
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
Speech audiometry
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
Speech audiometry
Time frame: From 1 to 90 days prior the fitting with device
Speech audiometry
Time frame: 6 months after the fitting with device, 12 months after the fitting with device
Audiometry
Time frame: 6 months after the fitting with device, 12 months after the fitting with device
Audiometry
Time frame: 6 months after the fitting with device, 12 months after the fitting with device
in case of uncooperative patients or to confirm tonal audiometry
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
in case of uncooperative patients or to confirm tonal audiometry
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
Time frame: From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with device
French validated version
University Hospital, Tours
Other
Auditory Rehabilitation With Hearing Aids and Cognition in Alzheimer Patients
Acronym: RACO-MA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05519137
Alzheimer Disease, Alzheimer's Disease
Menands, New York, United States
View Trial DetailsNCT04867616
Alzheimer Disease, Alzheimer's Disease
Fresno, California, United States
View Trial DetailsNCT02947893
Alzheimer Disease, Alzheimer's Disease
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06206824
Abnormalities, Multiple, Alzheimer Disease
Gières, France
View Trial Details